Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Immune Reconstitution

Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?

Bone Marrow Transplantation volume 30, pages 925–929 (2002)Cite this article

Abstract

Invasive aspergillosis (IA) is common in allogeneic SCT recipients, with an incidence of 4–10%. The majority of these infections are diagnosed several months after SCT and they are frequently associated with GVHD. The diagnosis is difficult and often delayed. Established IA is notoriously difficult to treat with a death rate of 80–90%. This review summarises recent data on this problem to assess whether there has been any progress. Effective prophylactic measures are still lacking. Severe immunosuppression is the main obstacle to the success of therapy. Recent and ongoing developments in diagnostic measures and new antifungal agents may improve treatment results to some extent, but Aspergillus infections still remain a formidable problem in allogeneic transplantation. Further studies in this field will focus on the role of various cytokines and combinations of antifungal agents.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. de Bock R . Epidemiology of invasive fungal infection in bone marrow transplantation Bone Marrow Transplant 1994 14: (Suppl. 5) S1 S2

    PubMed  Google Scholar 

  2. Jantunen E, Ruutu P, Niskanen L et al. Incidence and risk factors of invasive fungal infections in allogeneic BMT recipients Bone Marrow Transplant 1997 19: 801 808

    Article  CAS  PubMed  Google Scholar 

  3. Wald A, Leisenring W, Burik J-A, Bowden RA . Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation J Infect Dis 1997 175: 1459 1466

    Article  CAS  PubMed  Google Scholar 

  4. Marr KA, Carter RA, Crippa F et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients Clin Infect Dis 2002 34: 909 917

    Article  PubMed  Google Scholar 

  5. McWhinney PHM, Kibbler CC, Hamon MD et al. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years’ experience Clin Infect Dis 1993 17: 397 404

    Article  CAS  PubMed  Google Scholar 

  6. Saugier-Veber P, Devergie A, Sulahian A et al. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant recipients: results of a 5-year retrospective study Bone Marrow Transplant 1993 12: 121 124

    CAS  PubMed  Google Scholar 

  7. Morrison VA, Haake RJ, Weisdorf DJ . Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome Am J Med 1994 96: 497 503

    Article  CAS  PubMed  Google Scholar 

  8. Hovi L, Saarinen-Pihkala UM, Vettenranta K, Saxen H . Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years Bone Marrow Transplant 2000 26: 999 1004

    Article  CAS  PubMed  Google Scholar 

  9. Baddley JW, Stroud TP, Salzman D, Pappas PG . Invasive mold infections in allogeneic bone marrow transplant recipients Clin Infect Dis 2001 32: 1319 1324

    Article  CAS  PubMed  Google Scholar 

  10. Jantunen E, Piilonen A, Volin L et al. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients Bone Marrow Transplant 2000 25: 867 871

    Article  CAS  PubMed  Google Scholar 

  11. Paterson DL, Singh N . Invasive aspergillosis in transplant recipients Medicine 1999 78: 123 138

    Article  CAS  PubMed  Google Scholar 

  12. Offner F, Cordonnier C, Ljungman P et al. Impact of previous aspergillosis on the outcome of bone marrow transplantation Clin Infect Dis 1998 26: 1098 1103

    Article  CAS  PubMed  Google Scholar 

  13. Denning DW . Invasive aspergillosis Clin Infect Dis 1998 26: 781 805

    Article  CAS  PubMed  Google Scholar 

  14. Reichenberger F, Habicht J, Matt P et al. Diagnostic yield of bronchoscopy in histologically proven pulmonary aspergillosis Bone Marrow Transplant 1999 24: 1195 1199

    Article  CAS  PubMed  Google Scholar 

  15. Caillot D, Casanovas PO, Bernard A et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery J Clin Oncol 1997 15: 139 147

    Article  CAS  PubMed  Google Scholar 

  16. Jantunen E, Piilonen A, Volin L et al. Radiologically guided fine needle lung biopsies in the evaluation of focal pulmonary lesions in allogeneic stem cell transplant recipients Bone Marrow Transplant 2002 29: 353 356

    Article  CAS  PubMed  Google Scholar 

  17. Bretagne S, Costa J-M, Bart-Delabasse A et al. Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis Clin Infect Dis 1998 26: 1407 1412

    Article  CAS  PubMed  Google Scholar 

  18. Machetti M, Feasi M, Mordini N et al. Comparison of an enzyme immunoassay and a latex agglutination system for diagnosis of invasive aspergillosis in bone marrow transplant recipients Bone Marrow Transplant 1998 21: 917 921

    Article  CAS  PubMed  Google Scholar 

  19. Maertens J, Verhaegen J, Demuynck D et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis J Clin Microbiol 1999 37: 3223 3228

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Sulahian A, Boutboul F, Ribaud P et al. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and one pediatric hematology units during a 4-year prospective study Cancer 2001 91: 311 318

    Article  CAS  PubMed  Google Scholar 

  21. Maertens J, Verhaegen J, Lagrou K et al. Screening for circulating galactomannan as a non-invasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation Blood 2001 97: 1604 1610

    Article  CAS  PubMed  Google Scholar 

  22. Bretagne S, Costa JM, Marmoral KM et al. Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR J Clin Microbiol 1995 33: 1164 1168

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Einsele H, Quabeck K, Muller K-D . Prediction of invasive pulmonary aspergillosis from colonization of lower respiratory tract before marrow transplantation Lancet 1998 352: 1443

    Article  CAS  PubMed  Google Scholar 

  24. Einsele H, Hebart H, Roller G et al. Detection and identification of fungal pathogens in blood by using molecular probes J Clin Microbiol 1997 35: 1353 1360

    CAS  PubMed  PubMed Central  Google Scholar 

  25. van Burik J-A, Myerson D, Schreckhise RW, Bowden RA . Panfungal PCR assay for detection of fungal infection in human blood specimen J Clin Microbiol 1998 36: 1169 1175

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Hebart H, Loffler J, Meisner C et al. Early detection of Aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening J Infect Dis 2000 181: 1713 1719

    Article  CAS  PubMed  Google Scholar 

  27. Williamson ECM, Leeming JP, Palmer HM et al. Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction Br J Haematol 2000 108: 132 139

    Article  CAS  PubMed  Google Scholar 

  28. Ellis M, Spence D, de Pauw B et al. An EORTC international multicenter trial (EORTC number 19923) comparing two doses of liposomal amphotericin B for treatment of invasive aspergillosis Clin Infect Dis 1998 27: 1406 1412

    Article  CAS  PubMed  Google Scholar 

  29. Leenders ACAP, Daenen S, Jansen RLH et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections Br J Haematol 1998 103: 205 212

    Article  CAS  PubMed  Google Scholar 

  30. Walsh TJ, Finberg RW, Arndt C et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia New Engl J Med 1999 340: 764 771

    Article  CAS  PubMed  Google Scholar 

  31. Herbrecht R, Auvrignon A, Andres E et al. Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients Eur J Clin Microbiol Infect Dis 2001 20: 77 82

    CAS  PubMed  Google Scholar 

  32. Mehta J, Kelsey S, Chu P et al. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies Bone Marrow Transplant 1997 20: 39 43

    Article  CAS  PubMed  Google Scholar 

  33. Wingard JR . Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses Bone Marrow Transplant 1997 19: 343 347

    Article  CAS  PubMed  Google Scholar 

  34. Walsh TJ, Hiemenz JW, Seibel NL et al. Amphotericin B lipid complex for invasive fungal infections: analysis on safety and efficacy in 556 cases Clin Infect Dis 1998 26: 1383 1396

    Article  CAS  PubMed  Google Scholar 

  35. White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis Clin Infect Dis 1997 24: 635 642

    CAS  PubMed  Google Scholar 

  36. Noskin G, Pietrelli L, Gurwith M, Bowden R . Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients Bone Marrow Transplant 1999 23: 697 703

    Article  CAS  PubMed  Google Scholar 

  37. Wingard JR, White M, Anaissie E et al. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia Clin Infect Dis 2000 31: 1155 1163

    Article  CAS  PubMed  Google Scholar 

  38. Denning DW, Lee JY, Hostetler JS et al. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy of invasive pulmonary aspergillosis Am J Med 1994 97: 135 144

    Article  CAS  PubMed  Google Scholar 

  39. Foot ABM, Veys PA, Gibson BES . Itraconazole oral solution as antifungal prophylaxis in children undergoing stem cell transplantation or intensive chemotherapy for haematological disorders Bone Marrow Transplant 1999 24: 1089 1093

    Article  CAS  PubMed  Google Scholar 

  40. Winston DJ, Maziarz RT, Chandrasekar PH et al. Long-term antifungal prophylaxis in allogeneic bone marrow transplant patients: a multicenter, randomized trial of intravenous/oral itraconazole versus intravenous/oral fluconazole Blood 2001 98: 479a (abstr.)

    Google Scholar 

  41. Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis New Engl J Med 2002 347: 408 415

    Article  CAS  PubMed  Google Scholar 

  42. Denning DW, Ribaud P, Milpied N et al. Efficacy and safety of voriconazole in the treatment of invasive aspergillosis Clin Infect Dis 2002 34: 563 571

    Article  CAS  PubMed  Google Scholar 

  43. Keating GM, Jarvis B . Caspofungin Drugs 2001 61: 1121 1129

    Article  CAS  PubMed  Google Scholar 

  44. Maertens J, Raad I, Sable CA et al. Multicenter, noncomparative study to evaluate safety and efficacy of caspofungin (CAS) in adults with invasive aspergillosis (IA) refractory or intolerant to amphotericin B (AMB), AMB lipid formulations (lipid AMB), or azoles. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy p 370 poster 1103, Toronto 2000

  45. Rex JH, Bennett JE, Gallin JI et al. In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae J Infect Dis 1991 163: 649 852

    Article  Google Scholar 

  46. Reichenberger F, Habicht J, Kaim A et al. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases Am J Respir Crit Care Med 1998 158: 885 890

    Article  CAS  PubMed  Google Scholar 

  47. Salerno CT, Ouyang DW, Pederson TS et al. Surgical therapy for pulmonary aspergillosis in immunocompromised patients Ann Thorac Surg 1998 65: 1415 1419

    Article  CAS  PubMed  Google Scholar 

  48. Yeghen T, Kibbler CC, Prentice HG et al. Management of invasive aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution Clin Infect Dis 2000 31: 859 868

    Article  CAS  PubMed  Google Scholar 

  49. Kennedy CA, Adams GL, Neglia JP, Giebink GS . Impact of surgical treatment on paranasal fungal infections in bone marrow transplant patients Otolaryngol Head Neck Surg 1997 116: 610 616

    Article  CAS  PubMed  Google Scholar 

  50. Denning DW . Therapeutic outcome of invasive aspergillosis Clin Infect Dis 1996 23: 608 615

    Article  CAS  PubMed  Google Scholar 

  51. Ribaud P, Chastang C, Latge J-P et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation Clin Infect Dis 1999 28: 322 330

    Article  CAS  PubMed  Google Scholar 

  52. Jantunen E, Ruutu P, Piilonen A et al. Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients Bone Marrow Transplant 2000 26: 759 762

    Article  CAS  PubMed  Google Scholar 

  53. Hagensee ME, Bauwens JE, Kjos B, Bowden RA . Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984–1992 Clin Infect Dis 1994 19: 402 408

    Article  CAS  PubMed  Google Scholar 

  54. Schwartz S, Behre G, Heinemann V et al. Aerosolized amphotericin B inhalations as prophylaxis of invasive Aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial Blood 1999 93: 3654 3661

    CAS  PubMed  Google Scholar 

  55. Morgenstern GR, Prentice AG, Prentice HG et al. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies Br J Haematol 1999 105: 901 911

    Article  CAS  PubMed  Google Scholar 

  56. Sherertz RJ, Belani A, Krames BS et al. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients Am J Med 1987 83: 709 718

    Article  CAS  PubMed  Google Scholar 

  57. Hertenstein B, Kern WV, Schmeiser T et al. Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia Ann Hematol 1994 68: 21 26

    Article  CAS  PubMed  Google Scholar 

  58. Wingard JR . Fungal infections after bone marrow transplant Biol Blood Marrow Transplant 1999 5: 55 68

    Article  CAS  PubMed  Google Scholar 

  59. Tollemar J, Ringden O, Andersson S et al. Randomized double-blind study of liposomal amphotericin B (AmBisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients Bone Marrow Transplant 1993 12: 577 582

    CAS  PubMed  Google Scholar 

  60. Ruutu T, Volin L, Parkkali T et al. Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study Blood 2000 96: 2391 2398

    CAS  PubMed  Google Scholar 

  61. Heslop H . Haemopoietic stem cell transplantation from unrelated donors Br J Haematol 1999 105: 2 6

    CAS  PubMed  Google Scholar 

  62. Aversa F, Tabilio A, Velardi A et al. Treatment of high-risk acute leukemia with T-cell depleted stem cells from related donors with one fully mismatched HLA haplotype New Engl J Med 1998 339: 1186 1193

    Article  CAS  PubMed  Google Scholar 

  63. Carella AM, Champlin R, Slavin S et al. Mini-allografts: ongoing trials in humans Bone Marrow Transplant 2000 25: 345 350

    Article  CAS  PubMed  Google Scholar 

  64. Junghans C, Marr KA, Carter RA et al. Incidence of bacterial and fungal infections after nonmyeloablative compared to myeloablative allogeneic hematopoietic stem cell transplantation (HSCT) Blood 2001 98: 479a (Abstr.)

    Google Scholar 

  65. Grazziutti M, Przepiorka D, Rex JH et al. Dendritic cell-mediated stimulation of the in vitro lymphocyte response to Aspergillus Bone Marrow Transplant 2001 27: 647 652

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Kuopio University Hospital, Kuopio, Finland

    E Jantunen

  2. Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland

    V-J Anttila & T Ruutu

Authors
  1. E Jantunen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V-J Anttila
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Ruutu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jantunen, E., Anttila, VJ. & Ruutu, T. Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?. Bone Marrow Transplant 30, 925–929 (2002). https://doi.org/10.1038/sj.bmt.1703738

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703738

Keywords

This article is cited by

Search

Advanced search

Quick links